Skip to content

Preliminary study on blood pressure control in General anesthesia endovascular treatment of acute ischemic stroke

Preliminary study on blood pressure control in General anesthesia endovascular treatment of acute ischemic stroke

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300070764
Enrollment
Unknown
Registered
2023-04-23
Start date
2023-05-01
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cerebral apoplexy

Interventions

Intensive blood pressure group:Vasoactive drugs
Standard blood pressure group:The dose of continuous infusion was adjusted on the basis of changes in vital signs, with the safety threshold of 110 to 140 mm Hg for systolic blood pressure control by

Sponsors

Shanghai Changhai Hospital Anesthesiology Department
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Subjects must meet all the following criteria to be eligible for inclusion in the study: 1) Adult (age =18 years old) 2) The clinical diagnosis is acute ischemic stroke, and the imaging proves that it is great vascular occlusion (anterior circulation or posterior circulation). 3) mechanical embolectomy was performed within 24 hours after the onset of stroke. 4) mechanical embolectomy under general anesthesia 5)ASA classification: II-III. 6) BMI: 18.5 to 30kg/m2. 7) Sign the informed consent form (or agent signing)

Exclusion criteria

Exclusion criteria: Potential subjects will be excluded from this study if they meet any of the following criteria: 1) The responsible physician's judgment on the benefits of treatment is unclear (such as late dementia, severe disability in the past or extremely short life expectancy after embolectomy). 2) There are other diseases that interfere with clinical efficacy or follow-up evaluation (such as tumor, chronic airflow disease, severe heart failure, and definite post-stroke disability (mRS 3-5)). 3) allergic to any narcotic drugs or any other auxiliary materials 4) transplant surgery or transplant patients 5) Patients with aortic isthmus stenosis and arteriovenous shunt (except: patients with hemodynamic inactive dialysis shunt) 6) Lactating women 7) currently participating in other clinical trials and affecting the clinical prognosis evaluation. 8) heart, lung, liver, kidney and other important organ dysfunction.

Design outcomes

Primary

MeasureTime frame
MRS score at 90 days;

Secondary

MeasureTime frame
ICH;Image endpoint;Postoperative outcome;

Countries

China

Contacts

Public Contactlibinben

Shanghai Changhai Hospital Anesthesiology Department

libinben@126.com+86 13816439826

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026